Covid-19

Publications

2024

Gillot C, Tré-Hadry M, Cupaiolo R, Blairon L, Wilmet A, Beukinga I, Dogné JM, Douxfils J, Favresse J. Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273. Virology. 2024 Apr 8;595:110082.

Favresse J, Gillot C, Cabo J, David C, Dogné JM, Douxfils J. Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1 and JN.1 six months after the BNT162b2 bivalent booster. Int J Infect Dis. 2024 Apr 5:107028.

Favresse J, Gillot C, Closset M, Cabo J, Wauthier L, David C, Elsen M, Dogné JM, Douxfils J. Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster. J Med Virol. 2024 Jan;96(1):e29365.

2023

Mignolet M, Gilloteaux J, Halloin N, Gueibe M, Willemart K, De Swert K, Bielarz V, Suain V, Pastushenko I, Gillet NA, Nicaise C. Viral Entry Inhibitors Protect against SARS-CoV-2-Induced Neurite Shortening in Differentiated SH-SY5Y Cells. Viruses. 2023; 15(10):2020.

Callewaert C, Pezavant M, Vandaele R, Meeus B, Vankrunkelsven E, Van Goethem P, Plumacker A, Misset B, Darcis G, Piret S, De Vleeschouwer L, Staelens F, Van Varenbergh K, Tombeur S, Ottevaere A, Montag I, Vandecandelaere P, Jonckheere S, Vandekerckhove L, Tobback E, Wieers G, Marot JC, Anseeuw K, D'Hoore L, Tuyls S, De Tavernier B, Catteeuw J, Lotfi A, Melnik A, Aksenov A, Grandjean D, Stevens M, Gasthuys F, Guyot H. Sniffing out safety: canine detection and identification of SARS-CoV-2 infection from armpit sweat. Front Med (Lausanne). 2023 Sep 19;10:1185779.

Bizimungu C, Sabbe M, Wuillaume F, Hamdani J, Koch P, Dogné JM. Challenges in Assessing COVID-19 Vaccines Safety Signals-The Case of ChAdOx1 nCoV-19 Vaccine and Corneal Graft Rejection. Vaccines (Basel). 2023 May 6;11(5):954.

Dechamps M, De Poortere J, Octave M, Ginion A, Robaux V, Pirotton L, Bodart J, Gruson D, Van Dievoet MA, Douxfils J, Haguet H, Morimont L, Derive M, Jolly L, Bertrand L, Laterre PF, Horman S, Beauloye C. Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill. Int J Mol Sci. 2023 Apr 14;24(8):7278.

Durand J, Dogné JM, Cohet C, Browne K, Gordillo-Marañón M, Piccolo L, Zaccaria C, Genov G. Safety Monitoring of COVID-19 Vaccines: Perspective from the European Medicines Agency. Clin Pharmacol Ther. 2023 Jun;113(6):1223-1234.

Favresse J, Cabo J, Douxfils J. Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection. J Infect. 2023 Aug;87(2):e31-e32.

Cuypers L, Keyaerts E, Hong SL, Gorissen S, Menezes SM, Starick M, Van Elslande J, Weemaes M, Wawina-Bokalanga T, Marti-Carreras J, Vanmechelen B, Van Holm B, Bloemen M, Dogne JM, Dufrasne F, Durkin K, Ruelle J, De Mendonca R, Wollants E, Vermeersch P; COVID-19 Genomics Belgium Consortium; Boulouffe C, Djiena A, Broucke C, Catry B, Lagrou K, Van Ranst M, Neyts J, Baele G, Maes P, André E, Dellicour S, Van Weyenbergh J. Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks. Nat Aging. 2023 Jun;3(6):722-733.

Simon G, Favresse J, Gillot C, Closset M, Catry É, Dogné JM, Douxfils J, Wieërs G, Bayart JL. Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration. Clin Chem Lab Med. 2023 Apr 21;61(10):1875-1885.

Gillot C, Bayart JL, Closset M, Cabo J, Maloteau V, Dogné JM, Douxfils J, Favresse J. Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing. Clin Chem Lab Med. 2023 Apr 3;61(9):1670-1675.

Beyens M, Toscano A, Van Damme P, Dogné JM, Ebo D, Sabato V. Perceived high risk of COVID-19 vaccination: the revealing power of placebo. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1954-1956.

Bayart JL, Gillot C, Dogné JM, Roussel G, Verbelen V, Favresse J, Douxfils J. Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals. J Clin Virol. 2023 Feb 28;161:105419.

Hardy M, Michaux I, Bulpa P, Schonau B, Nicolay B, de Maistre E, Godon A, Lecompte T, Mullier F. Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study. Thromb Res. 2023 Jan;221:69-72.

Favresse J, Gillot C, Bayart JL, David C, Simon G, Wauthier L, Closset M, Dogné JM, Douxfils J. Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster. J Med Virol. 2023 Jan;95(1):e28164.

2022

Gillot C, Favresse J, Maloteau V, Mathieux V, Dogné JM, Mullier F, Douxfils J. Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome. Vaccines (Basel). 2022 Nov 30;10(12):2056.

Durand J, Dogné JM, Cohet C, Browne K, Gordillo Maranon M, Piccolo L, Zaccaria C, Genov G. Safety monitoring of COVID-19 vaccines: perspective from the European Medicines Agency. Clin Pharmacol Ther. 2022 Dec 16.

Buoninfante A, Andeweg A, Baker AT, Borad M, Crawford N, Dogné JM, Garcia-Azorin D, Greinacher A, Helfand R, Hviid A, Kochanek S, López-Fauqued M, Nazy I, Padmanabhan A, Pavord S, Prieto-Alhambra D, Tran H, Wandel Liminga U, Cavaleri M. Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. NPJ Vaccines. 2022 Nov 9;7(1):141.

Janssens R, Hanoteaux S, Maloux H, Klamer S, Laisnez V, Verhaegen B, Linard C, Lahousse L, Delputte P, Terwagne M, Marescaux J, Pype R, Didy C, Dierick K, Van Hoorde K, Lesenfants M. SARS-CoV-2 Surveillance in Belgian Wastewaters. Viruses. 2022 Sep 2;14(9):1950.

Morimont L, Dechamps M, David C, Bouvy C, Gillot C, Haguet H, Favresse J, Ronvaux L, Candiracci J, Herzog M, Laterre PF, De Poortere J, Horman S, Beauloye C, Douxfils J. NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study. Biomolecules. 2022 Jul 27;12(8):1038.

Favresse J, Bayart JL, David C, Gillot C, Wieërs G, Roussel G, Sondag G, Elsen M, Eucher C, Dogné JM, Douxfils J. Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity. Viruses. 2022 Jul 28;14(8):1653.

Catry E, Favresse J, Gillot C, Bayart JL, Frérotte D, Dumonceaux M, Evrard P, Mullier F, Douxfils J, Carlier FM, Closset M. Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination. Viruses. 2022 Jul 2;14(7):1470.

Tré-Hardy M, Piteüs S, Beukinga I, Blairon L. Clinical evaluation of the GSD NovaPrime® SARS-CoV-2 RTq-PCR assay. Diagn Microbiol Infect Dis. 2022 Jul;103(3):115718.

Petitjean SJL, Chen W, Koehler M, Jimmidi R, Yang J, Mohammed D, Juniku B, Stanifer ML, Boulant S, Vincent SP, Alsteens D. Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection. Nat Commun. 2022 May 10;13(1):2564.

Gillot C, Favresse J, Maloteau V, Dogné JM, Douxfils J. Identification of SARS-CoV-2 Neutralizing Antibody with Pseudotyped Virus-based Test on HEK-293T hACE2 Cells. Bio Protoc. 2022 Apr 5;12(7):e4377.

Hardy M, Bareille M, Lecompte T, Mullier F. Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply 'hyperfibrinolysis'. Thromb Res. 2022 Apr 25;214:63-64.

Favresse J, Dogné JM, Douxfils J. Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster. Clin Chem Lab Med. 2022 Apr 25;60(7):e153-e156.

Bayart JL, Degosserie J, Favresse J, Gillot C, Didembourg M, Djokoto HP, Verbelen V, Roussel G, Maschietto C, Mullier F, Dogné JM, Douxfils J. Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant. Viruses. 2022 Mar 22;14(4):654.

Van Vooren S, Grayson J, Van Ranst M, Dequeker E, Laenen L, Janssen R, Gillet L, Bureau F, Coppieters W, Devos N, Hengchen B, Wattiau P, Méhauden S, Verlinden Y, Van Baelen K, Pattery T, Valentin JP, Janssen K, Geraerts M, Smeraglia J, Hellemans J, Wytynck P, Mestdagh P, Besbrugge N, Höfer R, Nollet F, Vandesompele J, De Smet P, Lebon J, Vandewynckele E, Verstrepen S, Uten W, Capron A, Malonne H, Poels J, André E. Reliable and Scalable SARS-CoV-2 qPCR Testing at a High Sample Throughput: Lessons Learned from the Belgian Initiative. Life (Basel). 2022 Jan 21;12(2):159.

Tré-Hardy M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, Coman-Vlagea N, Della Vecchia A, Horeanga A, Papleux E, Vekemans M, Beukinga I, Blairon L. Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected. J Infect. 2022 Apr;84(4):e31-e33.

Dechamps M, De Poortere J, Martin M, Gatto L, Daumerie A, Bouzin C, Octave M, Ginion A, Robaux V, Pirotton L, Bodart J, Gerard L, Montiel V, Campion A, Gruson D, Van Dievoet MA, Douxfils J, Haguet H, Morimont L, Derive M, Jolly L, Bertrand L, Dumoutier L, Castanares-Zapatero D, Laterre PF, Horman S, Beauloye C. Inflammation-Induced Coagulopathy Substantially Differs Between COVID-19 and Septic Shock: A Prospective Observational Study. Front Med (Lausanne). 2022 Jan 17;8:780750.

Favresse J, Bayart JL, David C, Dogné JM, Douxfils J. Nucleocapsid Serum Antigen Determination in SARS-CoV-2 Infected Patients Using the Single Molecule Array Technology and Prediction of Disease Severity. J Infect. 2022 Apr;84(4):e4-e6.

Favresse J, Bayart JL, David C, Didembourg M, Gillot C, Dogné JM, Douxfils J. Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment. Clin Chem Lab Med. 2022 Jan 11;60(5):e97-e100.

Favresse J, Douxfils J. Importance of Sample Dilution in the Evaluation of the Antibody Response after SARS-CoV-2 Vaccination. J Infect. 2022 Jan;84(1):94-118.

Rodriguez EVC, Bouazza FZ, Dauby N, Mullier F, d'Otreppe S, Jissendi Tchofo P, Bartiaux M, Sirjacques C, Roman A, Hermans C, Cliquennois M. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US. Infection. 2022 Apr;50(2):531-536.

2021

Tré-Hardy M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, Della Vecchia A, Horeanga A, Papleux E, Vekemans M, Beukinga I, Blairon L. Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary. J Infect. 2021 Nov;83(5):559-564.

Gillot C, Favresse J, Maloteau V, Dogné JM, Douxfils J. Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects. Viruses. 2021 Nov 22;13(11):2329.

Mestdagh P, Gillard M, Dhillon SK, Pirnay JP, Poels J, Hellemans J, Hutse V, Vermeiren C, Boutier M, De Wever V, Soentjens P, Djebara S, Malonne H, André E, Arbyn M, Smeraglia J, Vandesompele J. Evaluating Diagnostic Accuracy of Saliva Sampling Methods for Severe Acute Respiratory Syndrome Coronavirus 2 Reveals Differential Sensitivity and Association with Viral Load. J Mol Diagn. 2021 Oct;23(10):1249-1258.

Favresse J, Gillot C, Douxfils J. Reply to Schulte-Pelkum, J. Comment on "Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. Microorganisms 2021, 9, 556". Microorganisms. 2021 Aug 31;9(9):1849.

Bayart J-L, Douxfils J, Gillot C, David C, Mullier F, Elsen M, Eucher C, Van Eeckhoudt S, Roy T, Gerin V, Wieers G, Laurent C, Closset M, Dogné J-M, Favresse J. Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers. Vaccines. 2021 Sep 28;9(10):1092.

Douxfils J, Gillot C, De Gottal É, Vandervinne S, Bayart JL, Dogné JM, Favresse J. Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature. Vaccines (Basel). 2021 Aug 15;9(8):907.

Tré-Hardy M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, Vecchia AD, Horeanga A, Papleux E, Vekemans M, Beukinga I, Blairon L. Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected. J Infect. 2021 Aug 23:S0163-4453(21)00433-3.

Gillot C, Favresse J, Mullier F, Lecompte T, Dogné JM, Douxfils J. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments. Front Pharmacol. 2021 Aug 5;12:708302.

Douxfils J, Gillot C, Mullier F, Favresse J. Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ. J Infect. 2021 Oct;83(4):e4-e5.

Douxfils J, Vayne C, Pouplard C, Lecompte T, Favresse J, Potier F, Gasser E, Mathieux V, Dogné JM, Gruel Y, Rollin J, Mullier F. Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels. Haematologica. 2021 Dec 1;106(12):3249-3252.

Favresse J, Gillot C, Di Chiaro L, Eucher C, Elsen M, Van Eeckhoudt S, David C, Morimont L, Dogné JM, Douxfils J. Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses. 2021 Jul 14;13(7):1364.

Blairon L, Cupaiolo R, Piteüs S, Beukinga I, Tré-Hardy M. The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another. J Virol Methods. 2021 Nov;297:114248.

Favresse J, Bayart JL, Mullier F, Elsen M, Eucher C, Eeckhoudt SV, Roy T, Wieers G, Laurent C, Dogné JM, Closset M, Douxfils J. Antibody titers decline 3-month post-vaccination with BNT162b2. Emerg Microbes Infect. 2021 Jul 7:1-8.

Godon A, Durand Z, Agier L, Lecompte T, Mullier F, Marlu R, de Maistre E, Tacquard C, Levy JH, Godier A, Susen S, Albaladejo P. Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study. Thromb Res. 2021 Sep;205:8-10.

Bayart JL, Morimont L, Closset M, Wieërs G, Roy T, Gerin V, Elsen M, Eucher C, Van Eeckhoudt S, Ausselet N, David C, Mullier F, Dogné JM, Favresse J, Douxfils J. Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2. Microorganisms. 2021 Jun 21;9(6):1340.

Tré-Hardy M, Cupaiolo R, Wilmet A, Beukinga I, Blairon L. Waning antibodies in SARS-CoV-2 naïve vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers. J Infect. 2021 Sep;83(3):381-412.

Dellicour S, Linard C, Van Goethem N, Da Re D, Artois J, Bihin J, Schaus P, Massonnet F, Van Oyen H, Vanwambeke SO, Speybroeck N, Gilbert M. Investigating the drivers of the spatio-temporal heterogeneity in COVID-19 hospital incidence-Belgium as a study case. Int J Health Geogr. 2021 Jun 14;20(1):29.

Blairon L, Cupaiolo R, Thomas I, Piteüs S, Wilmet A, Beukinga I, Tré-Hardy M. Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance. J Med Virol. 2021 Oct;93(10):5783-5788.

Douxfils J, Favresse J, Dogné JM, Lecompte T, Susen S, Cordonnier C, Lebreton A, Gosselin R, Sié P, Pernod G, Gruel Y, Nguyen P, Vayne C, Mullier F. Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb Res. 2021 Jul;203:163-171.

Hardy M, Michaux I, Dive A, Lecompte T, Mullier F. Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study. TH Open. 2021 May 12;5(2):e152-e154.

Bonil L, Lingas G, Coupeau D, Lucet J-C, Guedj J, Visseaux B, Muylkens B. Survival of SARS-CoV-2 on Non-Porous Materials in an Experimental Setting Representative of Fomites. Coatings. 2021; 11(4):371.

Favresse J, Bayart JL, Mullier F, Dogné JM, Closset M, Douxfils J. Early antibody response in healthcare professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2). Clin Microbiol Infect. 2021 Sep;27(9):1351.e5-1351.e7.

Bareille M, Hardy M, Douxfils J, Roullet S, Lasne D, Levy JH, Stépanian A, Susen S, Frère C, Lecompte T, Mullier F. Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review. J Clin Med. 2021 Apr 16;10(8):1740.

Tré-Hardy M, Cupaiolo R, Papleux E, Wilmet A, Horeanga A, Antoine-Moussiaux T, Vecchia AD, Beukinga I, Vekemans M, Blairon L. Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers. J Infect. 2021 Aug;83(2):237-279.

Favresse J, Douxfils J. Evaluations of SARS-CoV-2 serological assays performance need inclusion of long-term samples. J Clin Microbiol. 2021 May 19;59(6):e00487-21.

Favresse J, Cadrobbi J, Eucher C, Elsen M, Laffineur K, Dogné JM, Douxfils J. Clinical performances of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins. J Med Virol. 2021 Apr;93(4):2262-2269.

Favresse J, Eucher C, Elsen M, Gillot C, Van Eeckhoudt S, Dogné JM, Douxfils J. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. Microorganisms 2021 Mar 8;9(3):556.

Haguet H, Douxfils J, Eucher C, Elsen M, Cadrobbi J, Tré-Hardy M, Dogné JM, Favresse J. Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients. J Med Virol. 2021 May;93(5):3277-3281.

Thémans P, Dauby N, Schrooyen L, Lebout F, Delforge M, Nasreddine R, Libois A, Payen MC, Konopnicki D, Wuillaume F, Lescrainier C, Verlinden V, Dogné JM, Hamdani J, Musuamba FT. Model informed dosing of hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and gaps. Br J Clin Pharmacol. 2021 Feb;87(2):674-682.

Bielarz V, Willemart K, Avalosse N, De Swert K, Lotfi R, Lejeune N, Poulain F, Ninanne N, Gilloteaux J, Gillet N, Nicaise C. Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection. Brain Res. 2021 Feb 5:147344.

Favresse J, Gillot C, Oliveira M, Cadrobbi J, Elsen M, Eucher C, Laffineur K, Rosseels C, Van Eeckhoudt S, Nicolas JB, Morimont L, Dogné JM, Douxfils J. Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection. J Clin Med. 2021 Jan 13;10(2):E265.

Tré-Hardy M, Wilmet A, Beukinga I, Favresse J, Dogné JM, Douxfils J, Blairon L. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies. J Med Virol. 2021 Feb;93(2):803-811.

Hardy M, Michaux I, Lessire S, Douxfils J, Dogné JM, Bareille M, Horlait G, Bulpa P, Chapelle C, Laporte S, Testa S, Jacqmin H, Lecompte T, Dive A, Mullier F. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study. Thromb Res. 2021 Jan;197:20-23.

Blairon L, Piteüs S, Beukinga I, Tré-Hardy M. Development and implementation of a RT-qPCR extraction-free protocol for the detection of SARS-CoV-2 and impact on the turn-around-time. J Med Virol. 2021 Apr;93(4):2538-2542.

Blairon L, Mokrane S, Wilmet A, Dessilly G, Kabamba-Mukadi B, Beukinga I, Tré-Hardy M. Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak. J Infect. 2021 Jan;82(1):159-198.

2020

Favresse J, Elsen M, Eucher C, Laffineur K, Van Eeckhoudt S, Nicolas JB, Gillot C, Dogné JM, Douxfils J. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients. Clin Chem Lab Med. 2020 Dec 18;59(5):e179-e183.

Gillot C, Douxfils J, Cadrobbi J, Laffineur K, Dogné JM, Elsen M, Eucher C, Melchionda S, Modaffarri É, Tré-Hardy M, Favresse J. An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens. J Clin Med. 2020 Nov 21;9(11):E3752.

Hardy M, Michaux I, Lessire S, Douxfils J, Dogné JM, Bareille M, Horlait G, Bulpa P, Chapelle C, Laporte S, Testa S, Jacqmin H, Lecompte T, Dive A, Mullier F. Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data. Data Brief. 2020 Dec;33:106519.

Vanwambeke SO, Linard C, Gilbert M, Dellicour S. SARS-CoV-2 emergence and diffusion: a new disease manifesting human-environment interactions and a global geography of health. Curr Opin Environ Sustain. 2020 Oct 27.

Barakat T, Muylkens B, Su BL. Is Particulate Matter of Air Pollution a Vector of Covid-19 Pandemic? Matter. 2020 Oct 7;3(4):977-980.

Hardy M, Douxfils J, Dogné JM, Lessire S, Chatelain B, Testa S, Gouin-Thibault I, Gruel Y, Lecompte T, Mullier F. Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory? Ann Biol Clin (Paris). 2020 Oct 1;78(5):471-481.

Thémans P, Belkhir L, Dauby N, Yombi JC, De Greef J, Delongie KA, Vandeputte M, Nasreddine R, Wittebole X, Wuillaume F, Lescrainier C, Verlinden V, Kiridis S, Dogné JM, Hamdani J, Wallemacq P, Musuamba FT. Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization. Eur J Drug Metab Pharmacokinet. 2020 Dec;45(6):703-713.

Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC, Chen W, Derclaye S, Vincent SP, Soumillion P, Alsteens D. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun. 2020 Sep 11;11(1):4541.

Hardy M, Lecompte T, Douxfils J, Lessire S, Dogné JM, Chatelain B, Testa S, Gouin-Thibault I, Gruel Y, Medcalf RL, Ten Cate H, Lippi G, Mullier F. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory. Thromb J. 2020 Sep 7;18:17.

Candellier A, Scohy A, Gillet N, Muylkens B, Morelle J, Belkhir L, Coupeau D, Jadoul M, Goffin É. Absence of SARS-CoV-2 in the effluent of peritoneal dialysis patients. Perit Dial Int. 2020 Sep;40(5):499-503.

Coupeau D, Burton N, Lejeune N, Loret S, Petit A, Pejakovic S, Poulain F, Bonil L, Trozzi G, Wiggers L, Willemart K, André E, Laenen L, Cuypers L, Van Ranst M, Bogaerts P, Muylkens B, Gillet NA. SARS-CoV-2 Detection for Diagnosis Purposes in the Setting of a Molecular Biology Research Lab. Methods Protoc. 2020 Aug 18;3(3):E59.

Mairesse A, Favresse J, Eucher C, Elsen M, Tré-Hardy M, Haventith C, Gruson D, Dogné JM, Douxfils J, Göbbels P. High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies. Clin Biochem. 2020 Aug 25:S0009-9120(20)30817-1.

Hardy M, Douxfils J, Bareille M, Lessire S, Gouin-Thibault I, Fontana P, Lecompte T, Mullier F. Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitations. J Thromb Haemost. 2020 Nov;18(11):3121-3124.

Favresse J, Eucher C, Elsen M, Laffineur K, Dogné JM, Douxfils J. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study. Clin Chem Lab Med. 2020 Sep 25;58(10):e193-e196.

Favresse J, Eucher C, Elsen M, Graux C, Goebels P, Laffineur K, Nicolas JB, Dogné JM, Douxfils J. Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia. Br J Haematol. 2020 Jun 17.

Favresse J, Eucher C, Elsen M, Tré-Hardy M, Dogné JM, Douxfils J. Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies. Clin Chem. 2020 Aug 1;66(8):1104-1106.

Blairon L, Wilmet A, Beukinga I, Tré-Hardy M. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital. J Clin Virol. 2020 May 30;129:104472.

Tré-Hardy M, Wilmet A, Beukinga I, Dogné JM, Douxfils J, Blairon L. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody. Clin Chem Lab Med. 2020 Jul 28;58(8):1357-1364.

Tré-Hardy M, Blairon L, Wilmet A, Beukinga I, Malonne H, Dogné JM, Douxfils J. The role of serology for COVID-19 control: Population, kinetics and test performance do matter. J Infect. 2020 May 15:S0163-4453(20)30297-8.